S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
EPA:DIM

Sartorius Stedim Biotech (DIM) Stock Forecast, Price & News

€245.60
-3.10 (-1.25%)
(As of 05/31/2023 ET)
Compare
Today's Range
€244.50
€247.40
50-Day Range
€239.60
€308.60
52-Week Range
N/A
Volume
111,561 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
€441.33

DIM stock logo

About Sartorius Stedim Biotech (EPA:DIM) Stock

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

DIM Stock News Headlines

“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin
$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.
Lithium Has Boomed And This American Stock Is Ready..
Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!
See More Headlines
Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10,409
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€441.33
High Stock Price Forecast
€470.00
Low Stock Price Forecast
€390.00
Forecasted Upside/Downside
+77.5%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Joachim Kreuzburg (Age 57)
    Chairman & CEO
    Comp: $891k
  • Mr. Heiko Imöhl
    VP of Group Financing & Investor Relations
  • Ms. Petra Kirchhoff (Age 53)
    Head of Corp. Communications & IR
  • Mr. John Gerard Mackay (Age 60)
    Exec. VP of Marketing, Sales & Services for Lab Products and Services Division
  • Benedikt Orzelek
    Head of Investor Relations
  • Olivier Guitard
    Head of Controlling BPS













DIM Stock - Frequently Asked Questions

What is Sartorius Stedim Biotech's stock price forecast for 2023?

0 equities research analysts have issued twelve-month price targets for Sartorius Stedim Biotech's stock. Their DIM share price forecasts range from €390.00 to €470.00. On average, they anticipate the company's share price to reach €441.33 in the next year. This suggests a possible upside of 77.5% from the stock's current price.
View analysts price targets for DIM
or view top-rated stocks among Wall Street analysts.

How have DIM shares performed in 2023?

Sartorius Stedim Biotech's stock was trading at €302.50 at the start of the year. Since then, DIM stock has decreased by 17.8% and is now trading at €248.70.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Sartorius Stedim Biotech own?
What is Sartorius Stedim Biotech's stock symbol?

Sartorius Stedim Biotech trades on the EPA under the ticker symbol "DIM."

What is Sartorius Stedim Biotech's stock price today?

One share of DIM stock can currently be purchased for approximately €248.70.

How many employees does Sartorius Stedim Biotech have?

The company employs 10,409 workers across the globe.

How can I contact Sartorius Stedim Biotech?

The official website for the company is www.sartorius.com. The company can be reached via phone at 33 4 42 84 56 00.

This page (EPA:DIM) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -